Related Experiment Videos
Genomics in breast cancer-therapeutic implications
Per Eystein Lønning1, Therese Sørlie, Anne-Lise Børresen-Dale
1Breast Cancer Unit, Section of Oncology, Institute of Medicine, Haukeland University Hospital, Bergen, Norway.
DNA microarray techniques enable classifying tumors by gene expression, revealing distinct cancer subtypes with prognostic significance. While promising for understanding tumor behavior and resistance, clinical application requires further advancement.
Area of Science:
- Oncology
- Genomics
- Biotechnology
Background:
- DNA microarray techniques have revolutionized cancer research by enabling large-scale gene expression analysis.
- These technologies allow correlation of gene expression profiles with clinical parameters in malignancies.
Purpose of the Study:
- To review the implications of DNA microarray technologies in cancer research, particularly in breast cancer.
- To explore how gene expression profiling aids in classifying tumors and understanding their biological relevance and prognostic impact.
Main Methods:
- Review of studies utilizing DNA microarray technology in cancer research.
- Analysis of gene expression profiles to identify distinct tumor classes.
- Correlation of gene expression-based classification with clinical parameters and prognostic outcomes.
Main Results:
- DNA microarrays facilitate the identification of distinct tumor subclasses based on gene expression, independent of traditional staging and grading.
- These classifications have demonstrated significant prognostic impact, highlighting their biological relevance.
- Microarray data offers insights into tumor behavior mechanisms, prognosis, and potential drug resistance.
Conclusions:
- DNA microarray technology provides powerful tools for exploring tumor biology, prognosis, and drug resistance.
- Despite advances, microarray techniques are not yet ready for routine clinical implementation in defining prognostic factors or predicting therapy response.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview